Zota Health Care LImited - Asset Resilience Ratio

Latest as of March 2025: 0.68%

Zota Health Care LImited (ZOTA) has an Asset Resilience Ratio of 0.68% as of March 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Zota Health Care LImited current assets vs equity to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

Rs29.74 Million
≈ $321.63K USD Cash + Short-term Investments

Total Assets

Rs4.39 Billion
≈ $47.49 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2016–2025)

This chart shows how Zota Health Care LImited's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see balance sheet size of Zota Health Care LImited.

Liquid Assets Composition Over Time

This chart breaks down Zota Health Care LImited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore ZOTA long-term investments to assets to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents Rs14.87 Million 0.34%
Short-term Investments Rs14.87 Million 0.34%
Total Liquid Assets Rs29.74 Million 0.68%

Asset Resilience Insights

  • Limited Liquidity: Zota Health Care LImited maintains only 0.68% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company maintains a balanced mix of cash and short-term investments.

Zota Health Care LImited Industry Peers by Asset Resilience Ratio

Compare Zota Health Care LImited's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Tubize-Fin
BR:TUB
Biotechnology 2.50%
Dianthus Therapeutics Inc.
NASDAQ:DNTH
Biotechnology 63.98%
Tango Therapeutics Inc
NASDAQ:TNGX
Biotechnology 62.24%
Damora Therapeutics, Inc.
NASDAQ:DMRA
Biotechnology 0.00%
Wecome Pharmaceutical Co Ltd
SHE:300878
Biotechnology 0.67%
Tectonic Therapeutic, Inc.
NASDAQ:TECX
Biotechnology 86.66%
Relmada Therapeutics Inc
NASDAQ:RLMD
Biotechnology 95.25%
MediWound Ltd
F:M8W
Biotechnology 56.04%

Annual Asset Resilience Ratio for Zota Health Care LImited (2016–2025)

The table below shows the annual Asset Resilience Ratio data for Zota Health Care LImited.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-03-31 0.68% Rs29.74 Million
≈ $321.63K
Rs4.39 Billion
≈ $47.49 Million
+0.39pp
2024-03-31 0.29% Rs6.56 Million
≈ $70.94K
Rs2.28 Billion
≈ $24.69 Million
-1.01pp
2023-03-31 1.29% Rs20.46 Million
≈ $221.29K
Rs1.58 Billion
≈ $17.10 Million
-1.96pp
2022-03-31 3.25% Rs45.22 Million
≈ $489.02K
Rs1.39 Billion
≈ $15.04 Million
+0.16pp
2021-03-31 3.09% Rs26.39 Million
≈ $285.35K
Rs854.69 Million
≈ $9.24 Million
+1.26pp
2020-03-31 1.83% Rs16.21 Million
≈ $175.29K
Rs884.79 Million
≈ $9.57 Million
+1.83pp
2019-03-31 0.00% Rs120.00
≈ $1.30
Rs896.07 Million
≈ $9.69 Million
+0.22pp
2018-03-31 -0.22% Rs-2.00 Million
≈ $-21.63K
Rs917.94 Million
≈ $9.93 Million
+0.03pp
2016-03-31 -0.24% Rs-1.08 Million
≈ $-11.63K
Rs440.52 Million
≈ $4.76 Million
--
pp = percentage points

About Zota Health Care LImited

NSE:ZOTA India Biotechnology
Market Cap
$375.44 Million
Rs34.72 Billion INR
Market Cap Rank
#13836 Global
#684 in India
Share Price
Rs1144.50
Change (1 day)
+2.30%
52-Week Range
Rs1028.10 - Rs1687.00
All Time High
Rs1687.00
About

Zota Health Care Limited develops, manufactures, and markets pharmaceutical products in India and internationally. The company offers generic drugs, health supplements, over-the-counter products, wellness and ayurvedic products, and nutraceutical products. It provides various medicines for chronic ailments, such as diabetes, cardiac, and thyroid disorders. The company operates its retail stores u… Read more